Skip to Content

Join the 'Glaucoma / Intraocular Hypertension' group to help and get support from people like you.

Glaucoma / Intraocular Hypertension News

Contacts May One Day Be Used to Deliver Glaucoma Medication

Posted 30 Aug 2016 by Drugs.com

TUESDAY, Aug. 30, 2016 – A special type of contact lens has been designed to gradually deliver medication to the eye, researchers report. This kind of contact lens could help people who have a hard time using eye drops to treat conditions such as glaucoma, the study authors explained. The new study showed that the drug-dispensing lenses were able to effectively lower the eye pressure in monkeys with glaucoma at least as much as the standard eye drops used to treat the disease. "This promising delivery system removes the burden of administration from the patient and ensures consistent delivery of medication to the eye, eliminating the ongoing concern of patient compliance with dosing," study co-author Dr. Janet Serle said in a news release from the Massachusetts Eye and Ear Infirmary. Serle is a glaucoma specialist at Icahn School of Medicine at Mount Sinai in New York City. Glaucoma is ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Routine Eye Exams See Vision Problems You Miss

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Routine eye checkups often pick up unnoticed problems, particularly in older adults, a new study says. "In asymptomatic patients, comprehensive routine optometric eye examinations detect a significant number of new eye conditions and/or results in management changes," said the study's author, Elizabeth Irving, and her colleagues from the University of Waterloo in Ontario, Canada. More than half of people with no new symptoms or vision problems receive new prescriptions or treatment changes as a result of routine eye exams, the researchers found. The need for vision prescription changes was found for two out of five people, the study noted. Meanwhile, 16 percent were diagnosed with a new eye condition and 31 percent had a change in their ongoing care, researchers found. The study included data on nearly 6,400 patients who visited a university eye clinic over ... Read more

Related support groups: Eye Conditions, Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Uveitis, Iritis, Keratitis, Optic Nerve Disorder, Ocular Herpes Simplex, Retinal Disorders, Macular Edema, Diagnosis and Investigation, Corneal Ulcer, Corneal Abrasion, Glaucoma/Intraocular Hypertension, Chorioretinitis, Strabismus, Vitreomacular Adhesion, Glaucoma (Narrow Angle)

Could 'Zaps' to the Brain Help Fight Glaucoma?

Posted 3 Jul 2016 by Drugs.com

FRIDAY, July 1, 2016 – Electrical pulses to the brain may help restore vision in some partially blind patients, German researchers report. Glaucoma and other types of damage to the eye's optic nerve typically cause permanent damage. But, the new technique appears to kick-start the brain's visual control centers, the researchers explained. A 10-day treatment regimen – entailing upwards of nearly an hour a day of electrical pulses aimed directly into the eye – improved vision among patients who were losing their sight, the researchers said. "By giving currents through the eye, we force retinal cells connected to the brain to fire intensely," explained study author Dr. Bernhard Sabel, a member of the medical faculty at the Otto-von-Guericke University of Magdeburg. "This activates the brain's [vision] cells to function better again. And, 'what fires together, wires together.' " ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Diagnosis and Investigation, Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

25 Million Americans Will Struggle With Vision Problems by 2050

Posted 19 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – As baby boomers age, the number of Americans with vision problems and blindness is expected to double over the next three decades, a new study suggests. In 2015, slightly more than 12 million Americans had a vision problem. But by 2050, that number will rise to 25 million, the researchers predicted. "This study gives us a GPS for our nation's future eye health," said lead researcher Dr. Rohit Varma, a professor of ophthalmology at the University of Southern California Keck School of Medicine in Los Angeles. "Our group and others have shown in previous studies that those who suffer from vision loss not only have a decreased quality of life but can also experience both physical and mental health decline, including an increased risk for chronic health conditions such as diabetes, depression and even death," he said. The economic burden from vision loss and eye ... Read more

Related support groups: Glaucoma, Cataract, Macular Degeneration, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Visual Defect/Disturbance, Aphakia, Pseudophakia, Glaucoma with Pupillary Block

Health Tip: Putting Medicine in Your Eyes

Posted 16 Feb 2016 by Drugs.com

-- You may be wary about applying those new eyedrops prescribed by your doctor. The Cleveland Clinic recommends: Use warm water and soap to wash your hands, then dry with a clean towel. Either grab a mirror or lie down before applying the medicine. Look up at the ceiling, then use one hand to pull down the lower eyelid. Hold the medicine in your other hand, resting on your forehead if needed. Without letting the tip of the bottle or tube touch the eye, gently place the medicine inside your lower eyelid. Then close your eye. If you are taking both an ointment and an eye drop, put the eye drop in first. Wait about five minutes before applying the ointment. Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Macular Degeneration, Glaucoma (Open Angle), Conjunctivitis, Conjunctivitis - Bacterial, Blepharitis, Keratitis, Ocular Herpes Simplex, Eye Redness/Itching, Corneal Ulcer, Corneal Abrasion, Glaucoma/Intraocular Hypertension, Conjunctivitis - Allergic, Seasonal Allergic Conjunctivitis, Herpes Simplex Dendritic Keratitis, Blepharoconjunctivitis, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Green, Leafy Vegetables Each Day May Help Keep Glaucoma at Bay

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Eating green leafy vegetables daily may decrease the risk of glaucoma – a serious eye disease – by 20 percent or more over many years, a new study suggests. "We found those consuming the most green leafy vegetables had a 20 to 30 percent lower risk of glaucoma," said study leader Jae Kang. Kang is an assistant professor of medicine at Brigham and Women's Hospital and Harvard Medical School in Boston. Glaucoma is an eye condition that usually develops when fluid increases in the front part of the eye and causes pressure, damaging the optic nerve. It can lead to loss of vision, according to the U.S. National Eye Institute. Although the study found an association between eating more leafy greens and a lower risk of glaucoma, it didn't prove cause-and-effect. Kang's team followed nearly 64,000 participants in the Nurses' Health Study from 1984 through 2012, and ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Scientists Spot Three More Genes Linked to Glaucoma Risk

Posted 11 Jan 2016 by Drugs.com

MONDAY, Jan. 11, 2016 – The discovery of three more genes linked to the most common type of glaucoma could boost efforts to fight the eye disease, researchers report. The three newly identified genes associated with primary open angle glaucoma bring the total number of such genes to 15, according to the study published online Jan. 11 in Nature Genetics. "Just in time for Glaucoma Awareness Month (January), this unprecedented analysis provides the most comprehensive genetic profile of glaucoma to date," Dr. Paul Sieving, director of the U.S. National Eye Institute (NEI), said in an institute news release. "These findings open avenues for the pursuit of new strategies to screen for, prevent and treat glaucoma," he added. Glaucoma is the most common cause of irreversible vision loss, and it affects 60 million people worldwide and about 2.7 million Americans. The disease causes vision loss ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Glaucoma Patients Have False Notions of Pot's Ability to Treat Their Disease: Survey

Posted 23 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 23, 2015 – Glaucoma patients ask for marijuana prescriptions because they have false notions of its effectiveness in treating the eye disease, a new survey has found. And the trend toward legalization of marijuana has lent additional weight to those misconceptions, the results suggested. Recent research has shown that prescription eye drops are much more effective than marijuana in treating glaucoma, an eye disease that afflicts more than 2 million Americans, said survey author Dr. David Belyea. He is director of glaucoma services at the George Washington University School of Medicine & Health Sciences, in Washington, D.C. Eye doctors need to step up their education efforts and make sure that people understand that marijuana is an impractical option, Belyea and colleagues conclude in their report, which is published Dec. 23 in the journal JAMA Ophthalmology. Glaucoma ... Read more

Related support groups: Eye Conditions, Glaucoma, Glaucoma (Open Angle), Cannabis, Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

Diabetes Drug Metformin May Lower Glaucoma Risk

Posted 28 May 2015 by Drugs.com

THURSDAY, May 28, 2015 – The diabetes drug metformin was linked to a lower risk of developing the eye condition glaucoma in a new study. People who took the most metformin during the 10-year study period had a 25 percent reduced risk of glaucoma compared with people not taking the drug, researchers found. "Glaucoma is a leading cause of blindness worldwide and classic open-angle glaucoma develops in late middle age or late age. So we hypothesized that a drug that mimics caloric restriction, such as metformin, might reduce the risk of glaucoma," said lead researcher Julia Richards, a professor of ophthalmology and visual sciences at the University of Michigan in Ann Arbor. Exactly how metformin might reduce the risk of glaucoma isn't known, the researchers said. And, while this study found an association between metformin use and lower glaucoma risk, it wasn't designed to prove a ... Read more

Related support groups: Metformin, Glaucoma, Glucophage, Janumet, Glucophage XR, ActoPlus Met, Glumetza, Glyburide/Metformin, Janumet XR, Glaucoma/Intraocular Hypertension, Jentadueto, Avandamet, Glucovance, Glipizide/Metformin, Metformin/Pioglitazone, Fortamet, Kombiglyze XR, Riomet, ActosPlus Met, PrandiMet

Lupin Receives FDA Approval for Generic Lumigan Ophthalmic Solution 0.03%

Posted 23 Feb 2015 by Drugs.com

Mumbai, India and Baltimore, Maryland – February 23, 2015: Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Bimatoprost Ophthalmic Solution, 0.03% from the United States Food and Drugs Administration (FDA) to market a generic version of Allergan Inc.'s Lumigan Ophthalmic Solution, 0.03%. Lupin Pharmaceuticals Inc. (LPI), the company's U.S. subsidiary would commence marketing the product shortly. Lupin's Bimatoprost Ophthalmic Solution, 0.03% is the AT rated generic equivalent of Lumigan Ophthalmic Solution, 0.03% and is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Lupin's Bimatoprost Ophthalmic Solution, 0.03% filing was made from its Indore facility which was audited in January, 2015. Two Lupin facilities, the Lupin Bioresearch Center, Pune (LBC) and its ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Lumigan, Glaucoma/Intraocular Hypertension, Bimatoprost

Best Glaucoma Treatments Still a Puzzle, Task Force Reports

Posted 18 Feb 2013 by Drugs.com

MONDAY, Feb. 18 – Drugs and surgery can lower the hallmark inner-eye pressure characteristic of glaucoma – the second-leading cause of blindness in the United States. But research still hasn't identified the best ways to prevent significant vision loss and improve patient satisfaction, according to a prominent government medical group. The U.S. Preventive Services Task Force (USPSTF) reviewed dozens of studies and collective reviews on open-angle glaucoma, which accounts for about 90 percent of all cases, concluding there's inadequate evidence to directly compare the effectiveness of medical, surgical or laser treatments. The task force, comprised of 16 independent experts in prevention and evidence-based medicine, also said it couldn't determine whether glaucoma screening for adults without previous vision problems prevents blindness or enhances long-term health. "We know that ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension

U.S. Glaucoma Cases Jump 22 Percent Over Decade: Report

Posted 13 Dec 2012 by Drugs.com

THURSDAY, Dec. 13 – The prevalence of glaucoma in the United States is 22 percent higher than it was 10 years ago, a new report reveals. Researchers from Prevent Blindness America and the U.S. National Eye Institute reported that more than 2.7 million Americans aged 40 and older are affected by this eye disease, which can damage the optic nerve and gradually lead to blindness. Symptoms for glaucoma develop slowly, so the condition is also known as the "sneak thief of sight." The researchers pointed out in a joint news release that more than 50 percent of those who have glaucoma are not even aware of it. To increase awareness and educate people about glaucoma, Prevent Blindness America joined forces with other leading vision and eye health groups to declare January as National Glaucoma Awareness Month. Among the people at greatest risk for glaucoma are those who are older and have a ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

Coffee Might Raise Glaucoma Risk: Study

Posted 4 Oct 2012 by Drugs.com

THURSDAY, Oct. 4 – People who drink at least three cups of coffee a day might be increasing their risk of developing glaucoma, which can lead to vision loss or blindness, according to Harvard University researchers. Specifically, caffeinated coffee appears to be associated with a type of glaucoma called exfoliation glaucoma, which is characterized by tiny fibers peeling from the eye's lens that can cause a pressure build-up, the researchers said. "While caffeinated coffee has several health benefits, drinking three or more cups of caffeinated coffee was found to be associated with increased risk of developing exfoliation glaucoma, particularly among those with a family history of glaucoma," said lead researcher Jae Hee Kang, assistant professor of medicine at the Channing Division of Network Medicine at Brigham and Women's Hospital in Boston. The increased risk was on the order of 66 ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Glaucoma (Narrow Angle)

FDA Approves Zioptan (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication

Posted 13 Feb 2012 by Drugs.com

WHITEHOUSE STATION, N.J., Feb. 13, 2012 – Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved Zioptan (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution. Zioptan (pronounced zye-OP-tan) is approved for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Open-angle glaucoma is the most common form of glaucoma, while ocular hypertension is a condition characterized by an increase in pressure inside the eye. "Prostaglandin analogs are often used as a first line of treatment to lower intraocular pressure in patients with open-angle glaucoma. The approval of Zioptan will provide a new, effective option to lower IOP," said George L. Spaeth, M.D., Wills Eye Institute, Philadelphia, "I a ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension

Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

Posted 9 Feb 2012 by Drugs.com

ST. LOUIS, Feb. 9, 2012 /PRNewswire/ – Mobius Therapeutics, LLC, a St. Louis-based ophthalmic company, has received final approval from the U.S. Food and Drug Administration for the platform product, Mitosol. This initial indication is for the use of Mitosol in glaucoma surgery. With FDA approval, Mobius Therapeutics can start marketing and production efforts for Mitosol immediately. "The approval of Mitosol for use in glaucoma surgery represents the culmination of more than five years of work on the part of Mobius Therapeutics," said Ed Timm, President of Mobius Therapeutics. "It will provide surgeons, hospitals, and patients with enhanced convenience, safety, and consistency in the surgical treatment of glaucoma." Glaucoma is the second-leading cause of blindness in the United States. It is treated progressively, beginning with pharmaceuticals, then office intervention and finally ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Glaucoma/Intraocular Hypertension, Ophthalmic Surgery, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma

Related Drug Support Groups

Combigan, Zioptan, tafluprost, brimonidine / timolol